sacituzumab govitecan,,patritumab,trastuzumab deruxtecan
gilead sciences,astrazeneca,daiichi sankyo
['bcsm', 'patritumab', 'mbc', 'enhertu', 'trodelvy']
excellent summary of the 3 adcs discussed for mbc (enhertu, trodelvy, &amp; patritumab deruxtecan) by dr veronique dieras. adcs show incredible potential esp for heavily pre-treated pts, but ses need to be managed carefully. pts struggle to stay on adcs at full dose. #asco22 #bcsm 
Stage IV Breast Cancer Survivor & Advocate treated at Johns Hopkins #BCSM. Extroverted introvert who loves nature & traveling. Co-founder of GRASP @grasptweets